Vivelle-Dot vs. Climara
See how Vivelle-Dot and Climara compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Vivelle-Dot and Climara both deliver estradiol through a skin patch, but Vivelle-Dot is changed twice a week while Climara only needs changing once a week.
Vivelle-Dot's patches are smaller, from 2.5 to 10 cm², while Climara's range from 6.5 to 25 cm², so size and visibility on skin differ noticeably.
Climara offers six dose strengths, including a 0.06 mg option Vivelle-Dot doesn't have, giving slightly more room to fine-tune the dose.
Vivelle-Dot vs. Climara Drug Summary
Vivelle-Dot
Vivelle-Dot is an estradiol patch, a form of hormone replacement therapy, used to treat moderate to severe hot flashes and vaginal dryness from menopause, low estrogen from ovarian failure, and to help prevent osteoporosis after menopause. It's applied to the lower abdomen or buttock and changed twice a week.
Climara
Climara is also an estradiol patch used as hormone replacement therapy for the same core reasons: moderate to severe hot flashes, vaginal dryness from menopause, low estrogen from ovarian failure, and osteoporosis prevention. One patch is worn on the lower abdomen and changed just once a week.
Vivelle-Dot vs. Climara Side Effects
Vivelle-Dot
Climara
Vivelle-Dot vs. Climara Dosage
Vivelle-Dot
Climara
| STAGE | DOSE | WHEN |
| Starting dose | 0.025 mg/day patch | At the start |
| Maximum dose | 0.1 mg/day patch | If needed |
| Dose changes | 4 increases | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 0.025 mg/day patch | At the start |
| Maximum dose | 0.1 mg/day patch | If needed |
| Dose changes | 5 increases | As tolerated |
Vivelle-Dot
| STAGE | DOSE | WHEN |
| Starting dose | 0.025 mg/day patch | At the start |
| Maximum dose | 0.1 mg/day patch | If needed |
| Dose changes | 4 increases | As tolerated |
Climara
| STAGE | DOSE | WHEN |
| Starting dose | 0.025 mg/day patch | At the start |
| Maximum dose | 0.1 mg/day patch | If needed |
| Dose changes | 5 increases | As tolerated |
Vivelle-Dot vs. Climara Indications
Vivelle-Dot
Vivelle-Dot is FDA-approved for moderate to severe hot flashes and vaginal or vulvar dryness tied to menopause, for low estrogen from ovarian failure or hypogonadism, and for preventing bone loss after menopause. Some clinicians also prescribe it off-label as part of feminizing hormone therapy for transgender women.
Moderate to severe hot flashes (vasomotor symptoms) of menopause
Vaginal and vulvar dryness or atrophy from menopause
Low estrogen (hypoestrogenism) from ovarian failure, hypogonadism, or castration
Prevention of postmenopausal osteoporosis
Off-label: feminizing hormone therapy for transgender women
Climara
Climara carries the same core approvals: moderate to severe menopausal hot flashes, vaginal and vulvar atrophy, low estrogen from ovarian failure or hypogonadism, and prevention of postmenopausal osteoporosis. It's also used off-label as part of feminizing hormone therapy for transgender women.
Moderate to severe hot flashes (vasomotor symptoms) of menopause
Vaginal and vulvar dryness or atrophy from menopause
Low estrogen (hypoestrogenism) from ovarian failure, hypogonadism, or castration
Prevention of postmenopausal osteoporosis
Off-label: feminizing hormone therapy for transgender women
Vivelle-Dot vs. Climara Pros and Cons
Vivelle-Dot
Vivelle-Dot delivers the same estradiol hormone as other patches, so its cardiovascular, cancer, and dementia risks mirror Climara's. The real differences patients notice are patch size, how often it's changed, and the number of dose strengths available.
Pros
Smaller patch (2.5 to 10 cm²) that's less visible under clothing than Climara's larger sizes.
Twice-weekly changes may give steadier estrogen levels between applications than once-a-week dosing.
FDA-approved since 1996, with decades of real-world use in menopause care.
Cons
Requires a new patch twice a week instead of once, meaning more frequent site changes.
Comes in five dose strengths, one fewer than Climara's six, slightly limiting fine-tuning.
No manufacturer copay card is currently offered for brand-name Vivelle-Dot.
Climara
Climara delivers estradiol through the skin just like Vivelle-Dot, so it carries the same core estrogen-related risks and benefits. What sets it apart for patients is a larger patch, weekly rather than twice-weekly changes, and one extra dose strength.
Pros
Only needs changing once a week instead of twice, meaning fewer patch changes overall.
Offers six dose strengths, including a 0.06 mg option, for finer titration than Vivelle-Dot's five.
Longer FDA track record, approved since 1975, over two decades before Vivelle-Dot.
Cons
Larger patch (6.5 to 25 cm²) may be more visible under fitted clothing than Vivelle-Dot's smaller sizes.
Each patch holds more total hormone in reserve (up to 7.6 mg) than Vivelle-Dot's highest strength (up to 1.56 mg).
Once-a-week dosing means waiting longer to switch strengths if a dose isn't working well.
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.